# Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015

> **NCT02320656** · NA · COMPLETED · sponsor: **Institut Paoli-Calmettes** · enrollment: 650 (estimated)

## Conditions studied

- Acute Leukemia
- Myelodysplastic Syndromes
- Myeloproliferative Disorders

## Interventions

- **OTHER:** Blood sampling
- **OTHER:** Bone marrow aspirate
- **OTHER:** Skin biopsy
- **OTHER:** Buccal swab

## Key facts

- **NCT ID:** NCT02320656
- **Lead sponsor:** Institut Paoli-Calmettes
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2024-10-30
- **Final completion:** 2024-10-30
- **Target enrollment:** 650 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02320656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02320656, "Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02320656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*